Patents by Inventor John A. Andersen

John A. Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11118428
    Abstract: A method for performing a simulation of a field having a subterranean formation is described. The method includes obtaining phase behavior data of subterranean fluids of the field, generating an equation of state (EOS) model of the fluids based on the phase behavior data, generating a Helmholtz free energy model that reproduces predictions of the EOS model over a pre-determined pressure and temperature range, and performing the simulation of the field using the Helmholtz free energy model. The method may further include reducing the EOS model to a reduced EOS model having a reduced number of components to represent the EOS model over a pre-determined pressure and temperature range, generating the Helmholtz free energy model based on the reduced EOS model, and obtaining and using phase behavior data of injection fluids used. A computer system data.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: September 14, 2021
    Assignee: SCHLUMBERGER TECHNOLOGY CORPORATION
    Inventors: John Ratulowski, Denis Klemin, Mark Andersen, Oleg Dinariev, Nikolay Vyacheslavovich Evseev, Evgeny Ivanov, Sergey Sergeevich Safonov, Dmitry Anatolievich Koroteev
  • Publication number: 20210268237
    Abstract: An introducer tool including a housing, a sheath detachably coupled to the housing, and a needle fixed to the housing. The housing can include a guidewire actuating mechanism configured to extend and retract a guidewire fixed to the guidewire actuating mechanism. The sheath can include a handle, and can be detachably coupled to the housing in a first configuration of the introducer tool designed for venous introduction of the sheath. An end portion of the needle can extend past an end portion of the sheath in the first configuration of the introducer tool. Methods for venous access including obtaining and using the introducer tool are also disclosed.
    Type: Application
    Filed: June 19, 2019
    Publication date: September 2, 2021
    Inventors: Christian Andersen, John G. Evans
  • Publication number: 20210263342
    Abstract: An optical assembly includes an optically transparent substrate and a first lens removably coupled with the optically transparent substrate by one or more adhesive layers. The one or more adhesive layers are positioned between the optically transparent substrate and the first lens. Also disclosed are an eye-tracker and a display device, each of which includes the optical assembly.
    Type: Application
    Filed: February 21, 2020
    Publication date: August 26, 2021
    Inventors: Andrew John OUDERKIRK, Robin SHARMA, Karol Constantine HATZILIAS, Sheng YE, Sebastian SZTUK, Kirk Erik BURGESS, Javier San Agustin LOPEZ, Neeraj CHOUBEY, Bo Asp ANDERSEN, Kurt JENKINS
  • Publication number: 20210220715
    Abstract: A computer-implemented American soccer training and evaluation method that includes subjecting a drilling user to pre-defined drilling protocol(s) of a plurality of American soccer drilling assemblies and obtain, from each pre-defined drilling protocol(s) of the plurality of American soccer drilling assemblies and from at least one sensor on each of the assemblies, at least one user physical characteristic of the drilling user. The user physical characteristic is communicated to an administrative server over a network, where it is stored and used to create a drilling user performance profile having individualized performance comparisons with respect to the at least one user physical characteristic of the drilling user and a performance benchmark. Then, the drilling user performance profile is communicated to to at least one of a plurality of electronic computing devices of a plurality of consuming users for evaluation and review.
    Type: Application
    Filed: May 9, 2019
    Publication date: July 22, 2021
    Applicant: GOAL STATION APS
    Inventors: Holger Colding, Brian Sorensen, John Andersen, Lars Pedersen
  • Patent number: 11059795
    Abstract: The present invention relates to compounds of formula (I)-(VI) and/or (A)-(H-I), or any subgenera thereof, or a pharmaceutically acceptable salt, tautomer or stereoisomer. The compounds of the present disclosure are useful in modulating androgen receptor activity and for treating cancer including prostate cancer.
    Type: Grant
    Filed: April 20, 2020
    Date of Patent: July 13, 2021
    Assignees: ESSA Pharma, Inc., The University of British Columbia, Provincial Health Services Authority
    Inventors: Han-Jie Zhou, Peter Virsik, Raymond John Andersen, Marianne Dorothy Sadar
  • Publication number: 20210198213
    Abstract: Compounds having a structure of formula (I), (I-A), (Ia)-(Ie), (A)-(E), and (II) or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of disorders including prostate cancer are also provided.
    Type: Application
    Filed: May 24, 2019
    Publication date: July 1, 2021
    Inventors: Han-Jie Zhou, Peter Virsik, Raymond John Andersen, Marianne Dorothy Sadar, Kunzhong Jian, Daniel Andrew Golec
  • Publication number: 20210100757
    Abstract: Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, L1, L2, L3, X, a, b, c, n, and m are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity and uses as therapeutics as well as methods for treatment of subjects in need thereof, including prostate cancer are also provided.
    Type: Application
    Filed: December 9, 2020
    Publication date: April 8, 2021
    Inventors: Raymond John Andersen, Kunzhong Jian, Marianne Dorothy Sadar, Nasrin R. Mawji, Carmen Adriana Banuelos
  • Publication number: 20200325106
    Abstract: Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R11a, R11b, R11c, R11d, X, n1, n2, and n3 are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided.
    Type: Application
    Filed: May 1, 2020
    Publication date: October 15, 2020
    Inventors: Raymond John Andersen, Javier Garcia Fernandez, Kunzhong Jian, Marianne Dorothy Sadar, Nasrin R. Mawji, Carmen Adriana Banuelos
  • Publication number: 20200206155
    Abstract: Compounds having a structure of Formula I, or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, L1, L2, L3, X, a, b, c, n, and m are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity and uses as therapeutics as well as methods for treatment of subjects in need thereof, including prostate cancer are also provided.
    Type: Application
    Filed: October 1, 2019
    Publication date: July 2, 2020
    Inventors: Raymond John ANDERSEN, Kunzhong JIAN, Marianne Dorothy SADAR, Nasrin R. MAWJI, Carmen Adriana BANUELOS
  • Patent number: 10668503
    Abstract: A transfer conveyor assembly for a screening apparatus includes at least one transfer conveyor that is oriented transversely with respect to a feed direction of the screening apparatus and is configured to receive material from at least one respective screen deck of the screening apparatus. At least one intermediate transfer conveyor is positioned with respect to at least one further screen deck of the screening apparatus to receive material from the at least one further screen deck to feed material to a position away from the at least one transfer conveyor in a discharge direction of the screening apparatus.
    Type: Grant
    Filed: October 30, 2017
    Date of Patent: June 2, 2020
    Assignee: AAA SCREENS PTY LTD
    Inventor: John Andersen
  • Patent number: 10654811
    Abstract: Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R11a, R11b, R11c, R11d, X, n1, n2, and n3 are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided.
    Type: Grant
    Filed: January 13, 2016
    Date of Patent: May 19, 2020
    Assignees: The University of British Columbia, British Columbia Cancer Agency Branch
    Inventors: Raymond John Andersen, Javier Garcia Fernandez, Kunzhong Jian, Marianne Dorothy Sadar, Nasrin R. Mawji, Carmen Adriana Banuelos
  • Patent number: 10471023
    Abstract: Compounds having a structure of Formula I, or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, L1, L2, L3, X, a, b, c, n, and m are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity and uses as therapeutics as well as methods for treatment of subjects in need thereof, including prostate cancer are also provided.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: November 12, 2019
    Assignees: British Columbia Cancer Agency Branch, The University of British Columbia
    Inventors: Raymond John Andersen, Kunzhong Jian, Marianne Dorothy Sadar, Nasrin R. Mawji, Carmen Adriana Banuelos
  • Publication number: 20180327368
    Abstract: Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R11a, R11b, R11c, R11d, X, n1, n2, and n3 are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided.
    Type: Application
    Filed: January 13, 2016
    Publication date: November 15, 2018
    Applicants: THE UNIVERSITY OF BRITISH COLUMBIA UNIVERSITY-INDUSTRY LIAISON OFFICE, BRITISH COLUMBIA CANCER AGENCY BRANCH
    Inventors: Raymond John ANDERSEN, Javier Garcia FERNANDEZ, Kunzhong JIAN, Marianne Dorothy SADAR, Nasrin R. MAWJI, Carmen Adriana BANUELOS
  • Publication number: 20180235925
    Abstract: Compounds having a structure of Formula I: wherein G, a, Q, L2, R1, R2, R3, R4, R5 and R6 are as defined herein are provided. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided.
    Type: Application
    Filed: November 22, 2017
    Publication date: August 23, 2018
    Inventors: Raymond John Andersen, Javier Garcia Fernandez, Marianne Dorothy Sadar, Nasrin Mawji, Carmen Adriana Banuelos, Jun Wang
  • Publication number: 20180064657
    Abstract: Compounds having a structure of Formula I, or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, L1, L2, L3, X, a, b, c, n, and m are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity and uses as therapeutics as well as methods for treatment of subjects in need thereof, including prostate cancer are also provided.
    Type: Application
    Filed: March 11, 2016
    Publication date: March 8, 2018
    Inventors: Raymond John ANDERSEN, Kunzhong JIAN, Marianne Dorothy SADAR, Nasrin R. MAWJI, Carmen Adriana BANUELOS
  • Publication number: 20180065153
    Abstract: A transfer conveyor assembly for a screening apparatus includes at least one transfer conveyor that is oriented transversely with respect to a feed direction of the screening apparatus and is configured to receive material from at least one respective screen deck of the screening apparatus. At least one intermediate transfer conveyor is positioned with respect to at least one further screen deck of the screening apparatus to receive material from the at least one further screen deck to feed material to a position away from the at least one transfer conveyor in a discharge direction of the screening apparatus.
    Type: Application
    Filed: October 30, 2017
    Publication date: March 8, 2018
    Inventor: John Andersen
  • Patent number: 9808834
    Abstract: A mobile screening apparatus includes a support chassis. The support chassis is configured for carrying at least one screening assembly having a top screen deck and at least one further screen deck below the top screen deck. At least at least one primary feed mechanism is configured for arrangement in communication with any one or more of the top and further screen decks to feed material to be screened onto said any one or more of the top and further screen decks.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: November 7, 2017
    Assignee: AAA Screens Pty Ltd
    Inventor: John Andersen
  • Publication number: 20170121261
    Abstract: This invention provides compound having a structure of Formula I or Formula II. Uses of such compounds for treatment of various indications, including prostrate cancer as well as methods of treatment involving such compounds are also provided.
    Type: Application
    Filed: October 6, 2016
    Publication date: May 4, 2017
    Inventors: Marianne Dorothy SADAR, Jun WANG, Nasrin R. MAWJI, Raymond John ANDERSEN, David E. WILLIAMS, Mike LEBLANC
  • Publication number: 20160367707
    Abstract: Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R4, R5, X1, X2, X3 and X4 are are as defined herein, and wherein the compound comprises at least one F, Cl, Br, I or 123I moiety, are provided. Uses of such compounds for imaging diagnostics in cancer and therapeutics methods for treatment of subjects in need thereof, including prostate cancer as well as methods and intermediates for preparing such compounds are also provided.
    Type: Application
    Filed: May 17, 2016
    Publication date: December 22, 2016
    Inventors: Raymond John Andersen, Carmen Adriana Banuelos, Javier GARCIA FERNANDEZ, Yusuke IMAMURA, Jian KUNZHONG, Nasrin R. MAWJI, Marianne Dorothy SADAR, Jun WANG, Amy (Hsing Chen) Tien
  • Patent number: 9375496
    Abstract: Compounds having a structure of Formula I: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R4, R5, X1, X2, X3 and X4 are as defined herein, and wherein the compound comprises at least one F, Cl, Br, I or 123I moiety, are provided. Uses of such compounds for imaging diagnostics in cancer and therapeutics methods for treatment of subjects in need thereof, including prostate cancer as well as methods and intermediates for preparing such compounds are also provided.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: June 28, 2016
    Assignees: British Columbia Cancer Agency Branch, The University of British Columbia
    Inventors: Raymond John Andersen, Carmen Adriana Banuelos, Javier Garcia Fernandez, Yusuke Imamura, Jian Kunzhong, Nasrin R. Mawji, Marianne Dorothy Sadar, Jun Wang, Amy (Hsing Chen) Tien